Symbicort
is well tolerated in COPD patients and shows a similar frequency of
adverse events compared with the other treatments. In the study by Calverley et al fewer
patients receiving Symbicort withdrew from the study than those
receiving budesonide alone, formoterol alone or placebo.
|
